从全球物质监控系统中吸取教训:印度可以从中学到什么?
Aditya Vikram Singh1, Farida Ahmad1, Syed Shariq Naeem1
1Department of Pharmacology, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
Perspectives in clinical research
|February 16, 2026
概括
材料监控,监测医疗器械不良事件,对于患者安全至关重要. 发达国家有强大的系统,而印度则有.
科学领域:
- 医疗器械安全和监管科学.
- 加强公共卫生和医疗保健系统.
背景情况:
- 医疗器械在医疗保健中至关重要,但存在缺陷和不良事件的风险.
- 材料警对于监测,评估和预防医疗器械相关的危害至关重要.
- 发达国家拥有成熟的物质监管系统,具有强有力的监管监督和报告.
研究的目的:
- 分析全球和印度的物质监控现状.
- 确定印度不断发展的物质监控计划中的挑战.
- 提出加强印度医疗器械安全框架的战略.
主要方法:
- 对国际物质监控最佳实践进行比较分析.
- 审查印度的物质监控计划 (2015年).
- 识别挑战,包括报告,意识和执法.
主要成果:
- 已建立的国家使用全面的市场后监管,强调实时报告和问责制.
- 印度的计划面临挑战:有限的强制性报告,低意识,报告不足和不一致的执法.
- 全球最佳实践为印度的物质监控增强提供了路线图.
结论:
- 加强印度的物质警需要改进报告基础设施和利益相关者参与.
- 加强监管政策和执法对于确保印度医疗器械安全至关重要.
- 采用全球最佳实践可以大大提高印度医疗器械的安全性和可靠性.
关键词:
不良事件是不良事件.印度的物质监控计划.材料监控 材料监控 材料监控医疗器械 医疗器械是一种医疗器械.监管部门的监管机构.监控监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督更多相关视频
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
4.5K
09:07Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles
Published on: May 24, 2024
1.5K
相关概念视频
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Global Regulatory Systems
745
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
745
Principles of Disease Surveillance
591
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
591
Drug Regulation
3.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.1K
Drug Control Governance: Regulatory Bodies and Their Impact
575
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
575
Bioequivalence studies: Biowaivers
291
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
291
